HOME › DRUGS › ALITRETINOIN
ACTIVE SUBSTANCE / INN

ALITRETINOIN

Brand name(s): PANRETIN, Panretin
FDA LISTED
EMA LISTED
PRESCRIPTION
WITHDRAWN
Sarcoma, Kaposi
NDA020886
ACTIVE SUBSTANCE
Alitretinoin
REGULATORS
FDA · EMA
SPONSORS / MAH
ADVANZ PHARMA, Eisai GmbH
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
PANRETINNDA020886ADVANZ PHARMAPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
PanretinEisai GmbHWithdrawn11/10/2000Sarcoma, Kaposi

FULL INTELLIGENCE ON ALITRETINOIN

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →